SGHT Insider Trading
Insider Ownership Percentage: 28.90%
Insider Buying (Last 12 Months): $85,532.40
Insider Selling (Last 12 Months): $1,143,023.22
Sight Sciences Insider Trading History Chart
This chart shows the insider buying and selling history at Sight Sciences by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Sight Sciences Share Price & Price History
Current Price: $2.38
Price Change: ▲ Price Increase of +0.12 (5.31%)
As of 04/11/2025 05:00 PM ET
Sight Sciences Insider Trading History
Sight Sciences Institutional Trading History
Data available starting January 2016
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.
Read More on Sight Sciences
Volume
76,692 shs
Average Volume
208,986 shs
Market Capitalization
$122.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.46
Who are the company insiders with the largest holdings of Sight Sciences?
Sight Sciences' top insider shareholders include:
- Paul Badawi (CEO)
- D1 Capital Partners LP (Major Shareholder)
- David Badawi (CTO)
- Staffan Encrantz (Director)
- Matthew Link (Insider)
- Alison Bauerlein (CFO)
- Sam Boong Park (COO)
- Jeremy B Hayden (Insider)
- Manohar K Raheja (EVP)
Learn More about top insider investors at Sight Sciences.